177 related articles for article (PubMed ID: 21134560)
1. Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions.
Rabaglia JL; Kabbani W; Wallace L; Holt S; Watumull L; Pruitt J; Snyder WH; Nwariaku FE
Surgery; 2010 Dec; 148(6):1267-72; discussion 1272-3. PubMed ID: 21134560
[TBL] [Abstract][Full Text] [Related]
2. The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the quality of reporting, "risk" of malignancy, surgical rate, and rate of frozen sections requested for thyroid lesions.
Crowe A; Linder A; Hameed O; Salih C; Roberson J; Gidley J; Eltoum IA
Cancer Cytopathol; 2011 Oct; 119(5):315-21. PubMed ID: 21751427
[TBL] [Abstract][Full Text] [Related]
3. Thyroid cytopathology: Bethesda and beyond.
Ali SZ
Acta Cytol; 2011; 55(1):4-12. PubMed ID: 21135515
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of malignancy within cytologically indeterminate thyroid nodules.
Miller B; Burkey S; Lindberg G; Snyder WH; Nwariaku FE
Am J Surg; 2004 Nov; 188(5):459-62. PubMed ID: 15546550
[TBL] [Abstract][Full Text] [Related]
5. A histological assessment of the Bethesda system for reporting thyroid cytopathology (2010) abnormal categories: a series of 219 consecutive cases.
Tepeoğlu M; Bilezikçi B; Bayraktar SG
Cytopathology; 2014 Feb; 25(1):39-44. PubMed ID: 23438201
[TBL] [Abstract][Full Text] [Related]
6. Experience with standardized thyroid fine-needle aspiration reporting categories: follow-up data from 529 cases with "indeterminate" or "atypical" reports.
Nga ME; Kumarasinghe MP; Tie B; Sterrett GF; Wood B; Walsh J; Nguyen H; Whyte A; Frost FA
Cancer Cytopathol; 2010 Dec; 118(6):423-33. PubMed ID: 20945329
[TBL] [Abstract][Full Text] [Related]
7. The Bethesda System for Reporting Thyroid Cytopathology is applicable to frozen section diagnosis in children.
Arnold MA; Nicol KK
Pediatr Dev Pathol; 2015; 18(2):139-45. PubMed ID: 25625563
[TBL] [Abstract][Full Text] [Related]
8. The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the surgical treatment of thyroid nodules.
Richmond BK; O'Brien BA; Mangano W; Thompson S; Kemper S
Am Surg; 2012 Jun; 78(6):706-10. PubMed ID: 22643269
[TBL] [Abstract][Full Text] [Related]
9. A simplified Bethesda System for reporting thyroid cytopathology using only four categories improves intra- and inter-observer diagnostic agreement and provides non-overlapping estimates of malignancy risks.
Walts AE; Bose S; Fan X; Frishberg D; Scharre K; de Peralta-Venturina M; Zhai J; Marchevsky AM
Diagn Cytopathol; 2012 May; 40 Suppl 1():E62-8. PubMed ID: 21557534
[TBL] [Abstract][Full Text] [Related]
10. The Bethesda system for reporting thyroid cytopathology: An experience of 1,382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy.
Wu HH; Rose C; Elsheikh TM
Diagn Cytopathol; 2012 May; 40(5):399-403. PubMed ID: 21681976
[TBL] [Abstract][Full Text] [Related]
11. Improving prediction of malignancy of cytologically indeterminate thyroid nodules.
Tysome JR; Chandra A; Chang F; Puwanarajah P; Elliott M; Caroll P; Powrie J; Hubbard JG; Clarke SE; Jeannon JP; Simo R
Br J Surg; 2009 Dec; 96(12):1400-5. PubMed ID: 19918854
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes.
Wong LQ; Baloch ZW
Adv Anat Pathol; 2012 Sep; 19(5):313-9. PubMed ID: 22885380
[TBL] [Abstract][Full Text] [Related]
13. The Implementation of the Bethesda System for Reporting Thyroid Cytopathology Improves Malignancy Detection Despite Lower Rate of Thyroidectomy in Indeterminate Nodules.
Hirsch D; Robenshtok E; Bachar G; Braslavsky D; Benbassat C
World J Surg; 2015 Aug; 39(8):1959-65. PubMed ID: 25809059
[TBL] [Abstract][Full Text] [Related]
14. Routine second-opinion cytopathology review of thyroid fine needle aspiration biopsies reduces diagnostic thyroidectomy.
Davidov T; Trooskin SZ; Shanker BA; Yip D; Eng O; Crystal J; Hu J; Chernyavsky VS; Deen MF; May M; Artymyshyn RL
Surgery; 2010 Dec; 148(6):1294-9; discussion 1299-301. PubMed ID: 21134564
[TBL] [Abstract][Full Text] [Related]
15. Nodule size and fine-needle aspiration biopsy: diagnostic challenges for thyroid malignancy.
Rausei S; Dionigi G; Frattini F; Castano P; Leotta A; Rovera F; Boni L; Bartalena L; Dionigi R
Am J Surg; 2011 Apr; 201(4):525-30. PubMed ID: 20870208
[TBL] [Abstract][Full Text] [Related]
16. The Mcgill thyroid nodule score - does it help with indeterminate thyroid nodules?
Varshney R; Forest VI; Mascarella MA; Zawawi F; Rochon L; Hier MP; Mlynarek A; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2015 Feb; 44(1):2. PubMed ID: 25645364
[TBL] [Abstract][Full Text] [Related]
17. Impact of Afirma gene expression classifier on cytopathology diagnosis and rate of thyroidectomy.
Sacks WL; Bose S; Zumsteg ZS; Wong R; Shiao SL; Braunstein GD; Ho AS
Cancer Cytopathol; 2016 Oct; 124(10):722-728. PubMed ID: 27347838
[TBL] [Abstract][Full Text] [Related]
18. Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses.
Rossi M; Lupo S; Rossi R; Franceschetti P; Trasforini G; Bruni S; Tagliati F; Buratto M; Lanza G; Damiani L; Degli Uberti E; Zatelli MC
Endocrine; 2017 Jul; 57(1):98-107. PubMed ID: 27623969
[TBL] [Abstract][Full Text] [Related]
19. The impact of synoptic cytology reporting on fine-needle aspiration cytology of thyroid nodules.
Tsan CJ; Serpell JW; Poh YY
ANZ J Surg; 2007 Nov; 77(11):991-5. PubMed ID: 17931264
[TBL] [Abstract][Full Text] [Related]
20. [The role of fine-needle aspiration in the diagnosis of thyroid nodules].
Marrazzo A; Casà L; David M; Lo Gerfo D; Noto A; Taormina P
Chir Ital; 2005; 57(1):65-70. PubMed ID: 15832740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
